AbbVie Total Liab from 2010 to 2025
| ABBV Stock | USD 210.01 1.95 0.92% |
Total Liabilities | First Reported 2010-12-31 | Previous Quarter 137.4 B | Current Value 131.8 B | Quarterly Volatility 46.4 B |
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
AbbVie | Total Liab |
Latest AbbVie's Total Liab Growth Pattern
Below is the plot of the Total Liab of AbbVie Inc over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. AbbVie's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
| Total Liab | 10 Years Trend |
|
Total Liab |
| Timeline |
AbbVie Total Liab Regression Statistics
| Arithmetic Mean | 72,084,607,750 | |
| Geometric Mean | 51,228,991,590 | |
| Coefficient Of Variation | 65.29 | |
| Mean Deviation | 39,710,663,843 | |
| Median | 67,798,000,000 | |
| Standard Deviation | 47,067,223,898 | |
| Sample Variance | 2215323565.5T | |
| Range | 132B | |
| R-Value | 0.89 | |
| Mean Square Error | 492662788.2T | |
| R-Squared | 0.79 | |
| Slope | 8,800,497,053 | |
| Total Sum of Squares | 33229853482.3T |
AbbVie Total Liab History
About AbbVie Financial Statements
AbbVie investors use historical fundamental indicators, such as AbbVie's Total Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Liabilities | 131.8 B | 78.8 B |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.